Company Profile
Lifevantage Stock Price, News & Analysis
- Ticker:
- LFVN
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- United States
Stock performance
6.19 USD (-0.80%)
Close
Last updated: July 13, 2026 at 00:00
78.72M USD
Market cap
Why the stock is moving
LFVN is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
Lifevantage is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Lifevantage is followed within the biotech universe for its exposure to catalyst-driven execution.
Business Model Characteristics
Lifevantage follows a catalyst-driven model where the market watches how the company turns development work into repeatable value creation.
Position Within the Biotechnology Landscape
Compared with more mature healthcare peers, Lifevantage sits closer to the development side of the biotechnology landscape, where timing around data and approvals matters most.
Future catalysts
Recent news
The five most recent related feed items are shown below in reverse chronological order.
- 01
USANA Schedules Second Quarter 2026 Earnings Release and Conference Call
USNA · Source: Usana Health Sciences, Inc.
- 02
Zimmer Biomet Names Chintan Desai President of Asia Pacific Region
ZBH · Source: Zimmer Biomet
- 03
Herbalife Named to TIME's List of America’s Best Companies 2026
HLF · Source: Herbalife Nutrition
- 04
Zimmer Biomet Announces Webcast and Conference Call of Second Quarter 2026 Financial Results
ZBH · Source: Zimmer Biomet
- 05
U.S. Food and Drug Administration Accepts Bristol Myers Squibb's New Drug Application for Mezigdomide in Patients with Relapsed or Refractory Multiple Myeloma
BMY · Source: BMYBristol-Myers Squibb Company
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Lifevantage (LFVN)?
Lifevantage (LFVN) most recently closed at 6.19 USD, a -0.80% move versus the previous session.
What is the market cap of Lifevantage (LFVN)?
Lifevantage currently has a market capitalization of 78.72M USD on BioPharmSignal.
What does Lifevantage do?
Lifevantage is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
On which exchange is LFVN stock listed?
Lifevantage (LFVN) is associated with NASDAQ, United States, Biotechnology.
What is Lifevantage?
Lifevantage is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs.
Which conditions is Lifevantage targeting with Lifevantage?
Lifevantage is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
What is Investors?
Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.